Search results for: 'bioreactors tissue engines'

Software-defined vehicle (SDV) development is reshaping Europe’s automotive engineering service provider (ESP) market, shifting demand from capacity-led engineering support toward platform integration, software lifecycle management, validation automation, and compliance-by-design. This Frost & Sullivan analysis assesses how original equipment manuf...

The world's energy system is becoming more decentralized, with significant investments in generation assets at the commercial, industrial, and residential levels. One solution that has become popular is the installation of engines, as they can provide immediate base load or backup power. In today's competitive and regulated power engine market, ori...

This study covers engineered wood (EW) products (including plywood, oriented strand board (OSB), laminated veneer lumber (LVL), cross-laminated timber (CLT), medium- and high-density fiberboard (MDF, HDF), particleboard (or chipboard), glued laminated timber (glulam), and hardboard) and bonding agents (including melamine-urea-formaldehyde (MUF), ph...

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

This edition of the Industrial Bioprocessing TOE features information on carbon capture, waste conversion, wastewater treatment, bioreactors, artificial protein and plastic recycling among others.The Industrial Bioprocessing TOE provides intelligence on technologies, processes and strategic insights of industries involving bioprocessing, including ...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

The Alternative Wound Healing market encompasses many types of products, but this research service only profiles selected segments  Topical Hemostat (Collagen-based, Oxygen regenerated cellulose-based, Gelatin-based, Thrombin-based, Combination), Tissue Sealants (Fibrin-based, Protein-based, Synthetic-polymer-based), Cyanoacrylate based Tissue Adh...

This market study describes the U.S. market for hemostats, tissue sealants, tissue adhesives, and adhesion prevention products. The study includes forecasts of units, revenues and prices, as well as competitive structure and market share analysis for each segment. This report includes a PowerPoint executive summary of major conclusions, a total mar...

Recent cutbacks in EV investments due to lower consumer interest and higher raw material prices can boost alternative ICE vehicles, such as H2ICE, with lower price premiums that consumers can readily adopt in the short-to-medium term. ICEs running on hydrogen require minimal modifications and offer good customer value. These fuels can be made avail...